Metabolic biomarker discovery for risk of peripheral artery disease compared with coronary artery disease: Lipoprotein and metabolite profiling of 31 657 individuals from 5 prospective cohorts
Journal of the American Heart Association Dec 03, 2021
Tikkanen E, Jägerroos V, Holmes MV, et al. - In this study, the metabolic biomarker profile for future peripheral artery disease (PAD) risk was identified to be distinct from that of coronary artery disease (CAD), thus, indicating pathophysiological differences.
Five prospective cohorts from Finnish population (FINRISK 1997, 2002, 2007, and 2012, and Health 2000; n=31,657; median follow‐up time of 14 years) were used to examine links between >200 metabolic biomarkers and incident PAD and CAD.
Robust association of apolipoproteins and cholesterol measures with incident CAD (eg, hazard ratio [HR] per SD for higher apolipoprotein B/A‐1 ratio, 1.30), but not with incident PAD (HR per SD for higher apolipoprotein B/A‐1 ratio, 1.04), was revealed in age‐ and gender‐adjusted Cox models.
Triglyceride concentrations in low‐density lipoprotein and high‐density lipoprotein were found to be linked with both endpoints.
The following were strongly related to incident PAD: lower proportion of polyunsaturated fatty acids vs total fatty acids, and higher levels of monounsaturated fatty acids, glycolysis‐related metabolites, and inflammatory protein markers.
In addition, many of these links were stronger for PAD vs for CAD.
Most disparities in metabolic profiles for PAD and CAD continued when adjusting for conventional risk factors.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries